Maglangit, Marites G.
HRN: 06-02-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2022
CIPROFLOXACIN 500MG (TAB)
09/15/2022
09/21/2022
PO
500 Mg
Bid
Intestinal Amoebiasis, Uti,
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes